|
|
|
|
D-910 / D-910-1ML updated item number format
Diazepam-D5
1.0 mg/mL in Methanol | Certified Reference Material
|
|
Diazepam is a benzodiazepine used to treat a number of symptoms from anxiety and panic attacks to insomnia. This stable-labeled internal standard is suited for quantitation of diazepam levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, clinical toxicology, forensic analysis, or isotope dilution methods. Diazepam, a benzodiazpine frequently abused recreationally, is sold under the trade name Valium.
|
|
|
|
|
| Concentration:
|
1.0 mg/mL
|
| Solvent:
|
Methanol
|
| Unit Size:
|
1 mL/ampoule
|
| CAS Number:
|
65854-76-4
|
| Chemical Formula:
|
C16H8ClD5N2O
|
| Molecular Weight:
|
289.77
|
| Certificate of Analysis:
|
|
| US List Price:
|
|
|
|
|
| B-033 / B-033-1ML |
|
Benzodiazepine Multi-Component Mixture-8, 250 μg/mL of each component
|
|
$247.00
|
|
|
|
|
|
| D-142 / D-142-1ML |
|
Delorazepam, 100 μg/mL
|
|
$100.00
|
|
|
|
|
|
| D-902 / D-902-1ML |
|
Diazepam-D5, 100 μg/mL
|
|
$45.50
|
|
|
|
|
|
| D-907 / D-907-1ML |
|
Diazepam, 1.0 mg/mL
|
|
$28.20
|
|
|
|
|
|
| F-043 / F-043-1ML |
|
Flubromazepam, 1.0 mg/mL
|
|
$144.00
|
|
|
|
|
|
| H-113 / H-113-1ML |
|
3-Hydroxyphenazepam, 1.0 mg/mL
|
|
$244.00
|
|
|
|
|
|
| N-903 / N-903-1ML |
|
Nordiazepam-D5, 100 μg/mL
|
|
$46.90
|
|
|
|
|
|
| N-905 / N-905-1ML |
|
Nordiazepam, 1.0 mg/mL
|
|
$38.80
|
|
|
|
|
|
| N-911 / N-911-1ML |
|
Nordiazepam-D5, 1.0 mg/mL
|
|
$181.00
|
|
|
|
|
|
| P-080 / P-080-1ML |
|
Phenazepam, 1.0 mg/mL
|
|
$218.00
|
|
|
|
|
|
| P-093 / P-093-1ML |
|
Phenazepam-D4, 100 µg/mL
|
|
$241.00
|
|
|
|
|
Regulatory Control
▶ USDEA exempt chemical preparation - no USDEA registration or paperwork required
▶ Canada Test Kit Registration # 61-1157 - no Health Canada import authorization required
read more about ordering regulated substances
UN Number, Class, PG
1230, 3, II
Safety Data Sheet
HS Code
2845.90.0100
|
▶ Development of a High-Throughput LC-MS/MS Assay for a Pain Management Panel from Urine | IONICS Mass Spectrometry Group inc., 2014
|
|
▶ Proof of Concept for Automated SPE/HPLC/MS/MS Methods to Replace Traditional Immunoassay with MS Confirmation of Driving Under the Influence Samples | Robert M. Sears, Toxicology Technical Leader , Kenneth Lewis, CEO , and Kim Gamble, President, ITSP Solutions, INC., 2014
|
|
▶ Proof of Concept/Comparison of Automated SPE/HPLC/MS/MS Methods to Traditional Immunoassay with MS Confirmation in Death Investigation Cases | Robert M. Sears, Wendy C. Bell , Kenneth C. Lewis, Thurman L. Allsup and Kim Gamble, ITSP Solutions, INC., 2014
|
|
|
|
|